Hanno Matthaei

5.0k total citations · 2 hit papers
88 papers, 2.7k citations indexed

About

Hanno Matthaei is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hanno Matthaei has authored 88 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Surgery, 48 papers in Oncology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hanno Matthaei's work include Pancreatic and Hepatic Oncology Research (29 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers) and Pancreatitis Pathology and Treatment (10 papers). Hanno Matthaei is often cited by papers focused on Pancreatic and Hepatic Oncology Research (29 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers) and Pancreatitis Pathology and Treatment (10 papers). Hanno Matthaei collaborates with scholars based in Germany, United States and Spain. Hanno Matthaei's co-authors include Ralph H. Hruban, Anirban Maitra, Kenneth W. Kinzler, Jian Wu, Bert Vogelstein, Michael Goggins, Richard D. Schulick, Marco Dal Molin, Seung‐Mo Hong and Christopher L. Wolfgang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Hanno Matthaei

84 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

2011 562 citations Jian Wu, Hanno Matthaei et al. Science Translational Medicine profile →
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia

2012 534 citations Hanno Matthaei, Jian Wu et al. profile →

Peers

Countries citing papers authored by Hanno Matthaei

Since Specialization

Citations

This map shows the geographic impact of Hanno Matthaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanno Matthaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanno Matthaei more than expected).

Fields of papers citing papers by Hanno Matthaei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanno Matthaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanno Matthaei. The network helps show where Hanno Matthaei may publish in the future.

Co-authorship network of co-authors of Hanno Matthaei

This figure shows the co-authorship network connecting the top 25 collaborators of Hanno Matthaei. A scholar is included among the top collaborators of Hanno Matthaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanno Matthaei. Hanno Matthaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Figure S1 from The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma 2025 ·Figshare ·(unknown), Niklas Klümper, (unknown), (unknown), Vittorio Branchi, Alexander Semaan, (unknown), (unknown), Susanna S. Ng, Damian J. Ralser, (unknown), Hanno Matthaei, Jörg C. Kalff, (unknown), Veronika Lukacs‐Kornek, Glen Kristiansen, Maria A. González-Carmona, Michael Hölzel, Marieta Toma	0
2	The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma 2025 ·Molecular Cancer Therapeutics ·(unknown), Niklas Klümper, (unknown), (unknown), Vittorio Branchi, Alexander Semaan, (unknown), (unknown), Susanna S. Ng, Damian J. Ralser, (unknown), Hanno Matthaei, Jörg C. Kalff, (unknown), Veronika Lukacs‐Kornek, Glen Kristiansen, Maria A. González-Carmona, Michael Hölzel, Marieta Toma	1
3	The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids 2025 ·Biomedicines ·(unknown), (unknown), Leona Dold, Bettina Langhans, (unknown), Dominik J. Kaczmarek, Maria A. González-Carmona, Tobias J. Weismüller, Glen Kristiansen, Jörg C. Kalff, Michael Hölzel, Hanno Matthaei, Marieta Toma, Vittorio Branchi	2
4	Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma 2024 ·Human Pathology ·Vittorio Branchi, (unknown), (unknown), Susanna S. Ng, (unknown), (unknown), (unknown), (unknown), Leona Dold, Bettina Langhans, Maria A. González-Carmona, Saskia Ting, Glen Kristiansen, Jörg C. Kalff, Kevin Thurley, (unknown), Hanno Matthaei, Marieta Toma	1
5	IDEAL–compliant implementation of the Dexter ^® surgical robot in cholecystectomy: a comprehensive framework and clinical outcomes 2024 ·Innovative Surgical Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Joachim Schmidt, Jörg C. Kalff, Hanno Matthaei	1
6	Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: How We Do It 2023 ·Biology ·(unknown), (unknown), Hanno Matthaei, Steffen Manekeller, Jörg C. Kalff, Tim R. Glowka	2
7	Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer 2022 ·Diagnostics ·(unknown), Alexander Semaan, Makbule Kobilay, (unknown), Vittorio Branchi, (unknown), Karina Hettwer, Steffen Uhlig, Gunther Hartmann, Jörg C. Kalff, Hanno Matthaei, Philipp Lingohr, (unknown)	19
8	Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate 2022 ·Frontiers in Oncology ·(unknown), Robert Mahn, (unknown), Farsaneh Sadeghlar, Carsten H. Meyer, Marieta Toma, (unknown), Markus Essler, Tim R. Glowka, Hanno Matthaei, Jörg C. Kalff, Christian P. Strassburg, Maria A. González-Carmona	6
9	Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma 2021 ·Cancers ·Annabelle Vogt, Farsaneh Sadeghlar, (unknown), (unknown), (unknown), (unknown), Robert Mahn, (unknown), Michael Praktiknjo, Miroslaw Kornek, Marieta Toma, Ingo G.H. Schmidt‐Wolf, Vittorio Branchi, Hanno Matthaei, Jörg C. Kalff, Christian P. Strassburg, Maria A. González-Carmona	21
10	Tumor Infiltrating Neutrophils Are Frequently Found in Adenocarcinomas of the Biliary Tract and Their Precursor Lesions with Possible Impact on Prognosis 2021 ·Journal of Personalized Medicine ·Vittorio Branchi, (unknown), (unknown), Maria A. González-Carmona, Tobias J. Weismüller, Christian P. Strassburg, (unknown), Alexander Semaan, Philipp Lingohr, Steffen Manekeller, Glen Kristiansen, Jörg C. Kalff, Marieta Toma, Hanno Matthaei	6
11	A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer 2021 ·Diagnostics ·Vittorio Branchi, (unknown), (unknown), (unknown), (unknown), Philipp Lingohr, Maria A. González-Carmona, Marc Schmitz, Tobias J. Weismüller, Christian P. Strassburg, Steffen Manekeller, Glen Kristiansen, Jörg C. Kalff, Hanno Matthaei, Marieta Toma	3
12	Machine learning to guide clinical decision-making in abdominal surgery—a systematic literature review 2021 ·Langenbeck s Archives of Surgery ·(unknown), Andreas Buneß, Matthias Schmid, Jörg C. Kalff, Hanno Matthaei	18
13	Long Term Outcome After Open Abdomen Treatment: Function and Quality of Life 2021 ·Frontiers in Surgery ·(unknown), (unknown), Steffen Manekeller, Arnulf Willms, Dimitrios Pantelis, Hanno Matthaei, Nico Schäfer, Jörg C. Kalff, (unknown)	7
14	Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis 2018 ·Clinical Colorectal Cancer ·Alexander Semaan, Barbara Uhl, Vittorio Branchi, Philipp Lingohr, Friedrich Bootz, Glen Kristiansen, Jörg C. Kalff, Hanno Matthaei, Dimitrios Pantelis, Dimo Dietrich	12
15	Delayed gastric emptying following pancreatoduodenectomy with alimentary reconstruction according to Roux-en-Y or Billroth-II 2017 ·BMC Surgery ·Tim R. Glowka, (unknown), Hanno Matthaei, Nico Schäfer, Volker Schmitz, Jörg C. Kalff, Jens Standop, Steffen Manekeller	24
16	miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts 2012 ·Clinical Cancer Research ·Hanno Matthaei, Dennis Wylie, (unknown), Marco Dal Molin, Jon Kemppainen, Skye C. Mayo, Christopher L. Wolfgang, Richard D. Schulick, (unknown), Bernard F. Andruss, Alex Adai, Ralph H. Hruban, Anna E. Szafranska-Schwarzbach, Anirban Maitra	126
17	Mutant proteins as cancer-specific biomarkers 2011 ·Proceedings of the National Academy of Sciences ·Qing Wang, Raghothama Chaerkady, Jian Wu, Hee Jung Hwang, Nikolaos G. Papadopoulos, Levy Kopelovich, Anirban Maitra, Hanno Matthaei, James R. Eshleman, Ralph H. Hruban, Kenneth W. Kinzler, Akhilesh Pandey, Bert Vogelstein	128
18	Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development breakdown → 2011 ·Science Translational Medicine ·Jian Wu, Hanno Matthaei, Anirban Maitra, Marco Dal Molin, Laura D. Wood, James R. Eshleman, Michael Goggins, Marcia Irene Canto, Richard D. Schulick, Barish H. Edil, Christopher L. Wolfgang, Alison P. Klein, Luis A. Díaz, Peter J. Allen, C. Max Schmidt, Kenneth W. Kinzler, Nickolas Papadopoulos, Ralph H. Hruban, Bert Vogelstein	562
19	Presence of Pancreatic Intraepithelial Neoplasia in the Pancreatic Transection Margin does not Influence Outcome in Patients with R0 Resected Pancreatic Cancer 2011 ·Indian Journal of Surgical Oncology ·Hanno Matthaei, Seung‐Mo Hong, Skye C. Mayo, Marco Dal Molin, Kelly Olino, Raghunandan Venkat, Michael Goggins, Joseph M. Herman, Barish H. Edil, Christopher L. Wolfgang, John L. Cameron, Richard D. Schulick, Anirban Maitra, Ralph H. Hruban	2
20	Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas 2011 ·Human Pathology ·Marco Dal Molin, Seung‐Mo Hong, Sachidanand Hebbar, Rajni Sharma, Francesca Scrimieri, Roeland F. de Wilde, Skye C. Mayo, Michael Goggins, Christopher L. Wolfgang, Richard D. Schulick, Ming‐Tseh Lin, James R. Eshleman, Ralph H. Hruban, Anirban Maitra, Hanno Matthaei	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact